Natural Killer (NK) Cell Therapy is a form of immune cell therapy that utilizes NK cells, a naturally occurring population of lymphocytes that play an important role in the body’s innate immune defense and immune surveillance.
NK cells are capable of recognizing and eliminating certain virus infected, stressed, or abnormally transformed cells without requiring prior antigen specific sensitization.
At VISION Medical Concierge’s partner medical institutions, each patient undergoes medical evaluation by a qualified physician to determine whether NK cell therapy may be appropriate for their individual condition and treatment objectives.
In certain protocols using autologous NK cells, immune cells are collected from the patient’s own peripheral blood.
NK cells are subsequently isolated and expanded and/or activated under controlled conditions according to the cell processing protocol used by the relevant medical institution or cell processing facility.
Following preparation and quality control procedures, the cells are administered back to the patient, commonly by intravenous infusion, under medical supervision.
The therapeutic approach is designed to utilize the natural cytotoxic activity of NK cells and support the body’s immune surveillance mechanisms against abnormal cells.
NK cells are an important component of the innate immune system and contribute to:
Recognition of cells displaying abnormal or stress related characteristics
Cytotoxic activity against certain virus infected and transformed cells
Natural immune surveillance
Regulation and coordination of immune responses through cytokine signaling
These biological characteristics have made NK cells an important area of research and clinical development in cellular immunotherapy, particularly in oncology.
The specific protocol varies according to the medical institution, cell processing method, and individual treatment plan. A typical autologous NK cell therapy process may include:
The physician reviews the patient’s medical history, current health status, ongoing treatments, and relevant laboratory or diagnostic results.
For autologous NK cell therapy, peripheral blood is collected from the patient to obtain the immune cells required for cell processing.
The collected cells are processed under controlled conditions to expand and/or activate the NK cell population according to the applicable protocol.
Prior to administration, the prepared cellular product undergoes applicable quality and safety assessments according to the standards of the treating institution and cell processing facility.
The prepared NK cells are administered to the patient according to the physician’s treatment plan, commonly through intravenous infusion.
The patient’s condition is monitored following treatment, with further evaluation and treatment planning provided as medically appropriate.
NK cell therapy is not a one size fits all treatment.
The cell source, expansion and activation protocol, number of cells administered, number of treatment sessions, and treatment intervals may vary according to the patient’s medical condition, therapeutic objectives, and the protocol of the treating medical institution.
Treatment eligibility and planning should therefore be determined by the treating physician following an individual medical assessment.
VISION Medical Concierge supports patients throughout their medical journey by coordinating with partner medical institutions, assisting with medical documentation and appointments, providing interpretation support, and facilitating communication throughout the treatment process.
NK cell therapy is not suitable for every patient, and clinical outcomes may vary between individuals.
In oncology, NK cell therapy should not be interpreted as a routine replacement for established standard of care treatments such as surgery, chemotherapy, radiotherapy, or other indicated cancer therapies.
Its use should be evaluated by a qualified physician based on the patient’s condition, available medical evidence, current treatment plan, and applicable regulations.
VISION Medical Concierge provides medical coordination and support services and does not directly provide medical examinations, diagnoses, or treatments.
Application of advanced medical technologies to support the recovery, regeneration, and improvement of tissue and organ function in the body.
Use stem cells as directed by the medical facility to support tissue regeneration, functional recovery, and comprehensive health care.
The use of extracellular vesicles (exosomes) containing biological signaling molecules to support tissue recovery, regeneration, and overall health care.
Advanced screening programs help assess risk, detect early signs of abnormalities, and develop an appropriate follow-up plan.
Solutions designed to support the recovery of musculoskeletal function, including joints, tendons, ligaments, and soft tissues, with the goal of improving mobility and quality of life.
A comprehensive health care program that combines in-depth assessments with appropriate therapies to support overall health, help slow the aging process, and enhance quality of life.
Treatment will be provided by licensed hospitals and clinics in Japan.
No All medical services are provided by hospitals or clinics in Japan. VISION chịu trách nhiệm điều phối và hỗ trợ xuyên suốt hành trình.
Contact VISION for an initial consultation. After assessing your needs, we will recommend a suitable medical institution and program.
It depends on the program and the recommendations of the medical institution. Some programs may require only one visit, while others may involve follow-up appointments.
The cost depends on the program, medical institution, and each client’s individual condition. A quotation will be provided in advance before proceeding.
If available, clients are encouraged to provide previous examination results or medical records so that the physician has additional information for assessment.
Yes. VISION provides consultation and coordination support for the necessary arrangements related to the medical itinerary. The scope of support may vary depending on each individual case.
